- 1. MAN REPLACE INVERT UTER
- [ ] (UMLS (ICD9CM) C0177220) =Therapeutic or Preventive Procedure
| - 51. MANL REDUCT STOMA PROLAP
- (UMLS (ICD9CM) C0400305) =Therapeutic or Preventive Procedure ;
|
- 2. Managed
- [The act of conducting, controlling or supervising something. ( NCI )] (UMLS (NCI) C1273870) Management;
Managing;
=Occupational Activity | - 52. Manley Hot Springs Village
- (UMLS (HL7) C1550914) =Population Group =NativeEntityAlaska;
|
- 3. managed care
- [organized health care service in which provider must seek prior approval of the decision to treat a patient; if approved , the location, amount and type of care to be provided is agreed upon. ( CSP )] (UMLS (CSP) C0086583) =Health Care Activity ;
=health care service;
| - 53. mannan
- [polymers consisting of mannose residues, occurring in a variety of plants and as a cell wall constituent of some fungi. ( CSP )] (UMLS (CSP) C0024727) =Carbohydrate; Pharmacologic Substance ;
=glycan;
hexosan =acemannan;
guar gum;
|
- 4. Managed Care Organization
- (UMLS (HL7) C1552476) Managed Care Organizations;
=Manufactured Object; Health Care Related Organization =DRG Payor;
NUCC Health Care Provider Taxonomy =Preferred Provider Organization;
Exclusive Provider Organization;
Point of Service;
Health Maintenance Organization;
| - 54. Mannan-Binding Lectin
- [A recombinant protein similar or identical to human Mannan-binding lectin (MBL) that plays an important role in the innate immune defence. MBL is a plasma protein containing a carbohydrate recognition domain at one end and a collagen-like stalk domain at the other. The presence of multiple carbohydrate binding sites in a single molecule of MBL allows strong affinity to microorganisms. Upon binding, activation of the complement system leads to the deposition of complement components on the surface of the microorganisms (opsonisation) and to the clearance of the microorganisms by phagocytic cells. Administration of the agent to deficient individuals may restore lectin function in vivo, and thereby be beneficial in management of the immunodeficiency. ( NCI )] (UMLS (NCI) C0065661) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 5. Managed Care Organizations; Exclusive Provider Organization
- [(1) An EPO is a form of PPO, in which patients must visit a caregiver that is specified on its panel of providers (is a participating provider). If a visit to an outside(not participating) provider is made the EPO offers very limited or no coverage for the medical service; (2) While similar to a PPO in that an EPO allows patients to go outside the network for care, if they do so in an EPO, they are required to pay the entire cost of care. An EPO differs from an HMO in that EPO physicians do not receive capitation but instead are reimbursed only for actual services provided; (3) An organization identical to a preferred provider organization except that persons enrolled in the plan are eligible to receive benefits only when they use the services of the contracting providers. No benefits are available when non-contracting providers are used, except in certain emergency situations. ( HL7V3.0 )] (UMLS (HL7) C1551304) =Manufactured Object; Health Care Related Organization =HealthcareProviderTaxonomyHIPAA;
| - 55. mannequin
- [ ] (UMLS (CSP) C0024722) =Manufactured Object
|
- 6. Managed Care Organizations; Health Maintenance Organization
- [(1) A form of health insurance in which its members prepay a premium for the HMO's health services which generally include inpatient and ambulatory care. For the patient, an HMO means reduced out-of-pocket costs (i.e. no deductible), no paperwork (i.e. insurance forms), and only a small copayment for each office visit to cover the paperwork handled by the HMO; (2) A organization of health care personnel and facilities that provides a comprehensive range of health services to an enrolled population for a fixed sum of money paid in advance for a specified period of time. These health services include a wide variety of medical treatments and consults, inpatient and outpatient hospitalization, home health service, ambulance service, and sometimes dental and pharmacy services. The HMO may be organized as a group model, an individual practice association (IPA), a network model or a staff model. ( HL7V3.0 )] (UMLS (HL7) C1551305) =Manufactured Object; Health Care Related Organization =HealthcareProviderTaxonomyHIPAA;
| - 56. Mannich base
- [Ketonic amines prepared from the condensation of a ketone with formaldehyde and ammonia or a primary or secondary amine. A Mannich base can act as the equivalent of an alpha,beta unsaturated ketone in synthesis or can be reduced to form physiologically active amino alcohols. ( MSH )] (UMLS (CSP) C0024728) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
|
- 7. Managed Care Organizations; Point of Service
- [This product may also be called an open-ended HMO and offers a transition product incorporating features of both HMOs and PPOs. Beneficiaries are enrolled in an HMO but have the option to go outside the networks for an additional cost. ( HL7V3.0 )] (UMLS (HL7) C1551306) =Manufactured Object; Health Care Related Organization =HealthcareProviderTaxonomyHIPAA;
| - 57. Mannitol mustard
- [A nitrogen mustard derivative that cross-links with DNA, causing inhibition of DNA synthesis. It may be used to treat certain cancers, but may cause a higher incidence of leukemia and a dose-related incidence of lung tumors in animals. (NCI) ( NCI )] (UMLS (NCI) C0024738) =Organic Chemical; Pharmacologic Substance ;
|
- 8. Managed Care Organizations; Preferred Provider Organization
- [A group of physicians and/or hospitals who contract with an employer to provide services to their employees. In a PPO, the patient may got to the physician of his/her choice, even if that physician does not participate in the PPO, but the patient receives care at a lower benefit level. ( HL7V3.0 )] (UMLS (HL7) C1551307) =Manufactured Object; Health Care Related Organization =HealthcareProviderTaxonomyHIPAA;
| - 58. mannose
- [hexose or fermentable monosaccharide and isomer of glucose; occurs in oligosaccharides of many glycoproteins and glycolipids. ( CSP )] (UMLS (CSP) C0024742) =Carbohydrate; Pharmacologic Substance; Biologically Active Substance =hexose;
|
- 9. ManagedParticipationStatus
- [The status of an instance of the RIM Participation class. ( HL7V3.0 )] (UMLS (HL7) C1553754) =Intellectual Product =CodeSystem;
=normal;
nullified | - 59. mannose 6 phosphate
- [acts as a 'tag' for soluable lysosome enzyme transport to lysosomes. ( CSP )] (UMLS (CSP) C0065688) =Carbohydrate; Biologically Active Substance =sugar phosphate;
|
- 10. Manager
- (UMLS (HL7) C1546507) =Idea or Concept =Association;
| - 60. mannose 6 phosphate isomerase
- [An enzyme that catalyzes the reversible isomerization of D-mannose-6-phosphate to form D-fructose-6-phosphate, an important step in glycolysis. EC 5.3.1.8. ( MSH )] (UMLS (CSP) C0024744) =Amino Acid, Peptide, or Protein; Enzyme ;
=isomerase;
|
- 11. Manchester Band of Pomo Indians of the Manchester-
- (UMLS (HL7) C1554366) =Population Group =NativeEntityContiguous;
| - 61. mannosidase
- [Glycoside hydrolases that catalyze the hydrolysis of alpha or beta linked MANNOSE. ( MSH )] (UMLS (CSP) C0024746) =Amino Acid, Peptide, or Protein; Enzyme ;
=O glycosidase;
|
- 12. Manchester Terrier - Standard
- [The Manchester Terrier, originally called the Black and Tan Terrier, is a small, compact, agile dog with a long tapering head. The ears are v-shaped, and may be naturally folded over, pricked up, or cropped (in the toy variety, the ears must be naturally erect). The coat colors are black and tan. Height 15-16 inches (39-40 cm.) Average Weight: 17-18 pounds (7.7-8 kg.) ( NCI )] (UMLS (NCI) C0324397) =Mammal
| - 62. mannosidase deficiency
- [lysosomal storage disease due to defective alpha-mannosidase with resultant oligosaccharide accumulation. ( CSP )] (UMLS (CSP) C1257960) mannosidosis =Disease or Syndrome ;
=Carbohydrate Metabolism, Inborn Errors;
inborn lysosomal enzyme disorder;
enzyme deficiency;
|
- 13. Manchester Terrier - Toy
- [The Toy Manchester Terrier is a smaller, toy variety of the Standard Manchester Terrier. ( NCI )] (UMLS (NCI) C0324398) =Mammal
| - 63. Mannosylerythritol Lipid
- [A yeast glycolipid biosurfactant with potential antineoplastic activity. Mannosylerythritol lipid activates protein kinase signal cascades, resulting in cell differentiation, condensation of chromatin, DNA fragmentation, G1 phase cell-cycle arrest, and apoptosis of tumor cells. (NCI04) ( NCI )] (UMLS (NCI) C1099170) =Lipid; Pharmacologic Substance ;
|
- 14. MAND ORTHOGNATHIC OP NEC
- [ ] (UMLS (ICD9CM) C0177312) =Therapeutic or Preventive Procedure
| - 64. Manokotak Village
- (UMLS (HL7) C1550915) =Population Group =NativeEntityAlaska;
|
- 15. Mandan
- (UMLS (HL7) C1551959) =Language =Siouan;
| - 65. Manpower
- [The labor force available to do work on a project ( NCI )] (UMLS (NCI) C0700103) =Quantitative Concept ;
|
- 16. Mandatory
- [Indicates with a value of "True" whether the inclusion of an attribute in an HMD and in the messages derived from that HMD is mandatory. The default is not mandatory, and use of mandatory inclusion in the RIM is deprecated. ( HL7V3.0 )] (UMLS (HL7) C1554132) =Idea or Concept =HL7DefinedRoseProperty;
◊ [The message element must appear every time the message is communicated and its value must not be null. This condition is subject to the rules of multiplicity and conditionality. If a non-null default value is defined for the element, a null value may be communicated. ( HL7V3.0 )] (UMLS (HL7) C1619643) Required - V2.x Idea or Concept HL7ConformanceInclusion; | - 66. Mansonella ozzardi
- [ ] (UMLS (CSP) C0024757) =Invertebrate
|
- 17. mandelate
- [ ] (UMLS (CSP) C0178737) =Organic Chemical; Pharmacologic Substance
| - 67. MANSONELLA OZZARDI INFEC
- (UMLS (ICD9CM) C0016089) =Disease or Syndrome
|
- 18. Mandelic Acid
- (UMLS (NCI) C0065636) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
| - 68. MANTLE CELL LYM XTRRNDL
- [ ] (UMLS (ICD9CM) C1955691) Mantle cell lymphoma, unspecified site, extranodal and solid organ sites;
=Neoplastic Process |
- 19. Mandible Fracture
- [Fractures of the lower jaw. ( MSH )] (UMLS (NCI) C0024692) =Injury or Poisoning ;
=jaw fracture;
| - 69. MANTLE CELL LYMPH ABDOM
- [ ] (UMLS (ICD9CM) C1955694) Mantle cell lymphoma involving intra-abdominal lymph nodes;
=Neoplastic Process |
- 20. MANDIBLE FX NOS-OPEN
- [ ] (UMLS (ICD9CM) C0159334) =Injury or Poisoning
| - 70. MANTLE CELL LYMPH AXILLA
- [ ] (UMLS (ICD9CM) C1955695) Mantle cell lymphoma involving lymph nodes of axilla and upper limb;
=Neoplastic Process |
- 21. Mandible/Mandibular
- (UMLS (HL7) C1550275) =Body Part, Organ, or Organ Component =Body Part;
| - 71. MANTLE CELL LYMPH HEAD
- [ ] (UMLS (ICD9CM) C1955692) Mantle cell lymphoma involving lymph nodes of head, face, and neck;
=Neoplastic Process |
- 22. mandible/maxilla
- [the mandible is the horseshoe-shaped bone forming the lower jaw, the maxilla form the upper jaw. ( CSP )] (UMLS (CSP) C0178738) =Body Part, Organ, or Organ Component ;
=jaw;
=mandibular condyle;
| - 72. MANTLE CELL LYMPH INGUIN
- [ ] (UMLS (ICD9CM) C1955696) Mantle cell lymphoma involving lymph nodes of inguinal region and lower limb;
=Neoplastic Process |
- 23. mandibular condyle
- [posterior process on the ramus of the mandible composed of two parts: a superior part, the articular portion, and an inferior part, the condylar neck. ( CSP )] (UMLS (CSP) C0024688) =Body Part, Organ, or Organ Component ;
=mandible/maxilla;
| - 73. MANTLE CELL LYMPH MULTIP
- [ ] (UMLS (ICD9CM) C1955699) Mantle cell lymphoma involving lymph nodes of multiple sites;
=Neoplastic Process |
- 24. MANDIBULAR HYPERPLASIA
- [ ] (UMLS (ICD9CM) C0302501) =Anatomical Abnormality
| - 74. MANTLE CELL LYMPH PELVIC
- [ ] (UMLS (ICD9CM) C1955697) Mantle cell lymphoma involving intrapelvic lymph nodes;
=Neoplastic Process |
- 25. MANDIBULAR HYPOPLASIA
- (UMLS (ICD9CM) C0240295) =Anatomical Abnormality ;
| - 75. MANTLE CELL LYMPH SPLEEN
- [ ] (UMLS (ICD9CM) C1955698) Mantle cell lymphoma involving spleen;
=Neoplastic Process |
- 26. mandibular nerve
- [A branch of the trigeminal (5th cranial) nerve. The mandibular nerve carries motor fibers to the muscles of mastication and sensory fibers to the teeth and gingivae, the face in the region of the mandible, and parts of the dura. ( MSH )] (UMLS (CSP) C0024695) =Body Part, Organ, or Organ Component ;
| - 76. MANTLE CELL LYMPH THORAX
- [ ] (UMLS (ICD9CM) C1955693) Mantle cell lymphoma involving intrathoracic lymph nodes;
=Neoplastic Process |
- 27. MANDIBULAR RECONST NEC
- [ ] (UMLS (ICD9CM) C0177304) =Therapeutic or Preventive Procedure
| - 77. Mantle Cell Lymphoma of Small Intestine
- (UMLS (NCI) C1336003) Mantle Cell Lymphoma of the Small Intestine;
Small Intestinal Mantle Cell Lymphoma =Neoplastic Process |
- 28. mandrill
- [ ] (UMLS (CSP) C0324814) =Mammal
| - 78. Mantle Cell Lymphoma Refractory
- [Mantle cell lymphoma resistant to treatment ( NCI )] (UMLS (NCI) C0855138) Refractory Mantle Cell Lymphoma;
=Neoplastic Process |
- 29. Manduca
- [large grey moth; larval form of this genus is known to do considerable damage to the commercially important plants they feed on. ( CSP )] (UMLS (CSP) C0242620) =Invertebrate ;
=Lepidoptera;
| - 79. Mantle Cell Lymphoma Stage I
- [Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE).-2003 ( NCI )] (UMLS (NCI) C0677683) =Neoplastic Process
|
- 30. Manduca sexta
- [ ] (UMLS (CSP) C0242619) =Invertebrate ;
| - 80. Mantle Cell Lymphoma Stage II
- [Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). - 2003 ( NCI )] (UMLS (NCI) C0677745) =Neoplastic Process ;
|
- 31. Mangafodipir Trisodium
- (UMLS (NCI) C0067297) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =MANGAFODIPIR;
=MANGAFODIPIR TRISODIUM 37.9 MG/ML | - 81. Mantle Cell Lymphoma Stage III
- [Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). - 2003 ( NCI )] (UMLS (NCI) C0677714) =Neoplastic Process ;
|
- 32. manganese
- [trace element with atomic symbol Mn, atomic number 25; concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone; influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes. ( CSP )] (UMLS (CSP) C0024706) =Biologically Active Substance; Element, Ion, or Isotope =Micronutrient;
heavy metal;
[TN499] ELECTROLYTES/MINERALS, OTHER;
=MANGANESE (AS CHLORIDE);
MANGANESE (AS SULFATE);
VICON FORTE CAP;
CENTRUM TAB;
CERTAGEN TAB;
CHOICE DM LIQUID,BOTTLE,1000ML;
ISOCAL LIQUID,CAN,240ML;
ISOCAL LIQUID,CAN,360ML;
ISOCAL LIQUID,CAN,960ML;
MAGNACAL NUTRITIONAL SUPPLEMENT LIQUID;
MATERNA PRENATAL TAB;
MINERALS W/MULTIVITAMINS TAB;
MULTIVITAMINS W/MINERALS LIQUID;
GLUTOFAC TAB;
MANGANESE 15 MG;
MANGANESE 5 MG;
TRAUM-AID HBC PWDR (LEMONCREME);
GENERIX T CAP,SA;
MANGANESE 2.5 MG;
MANGANESE 1 MG;
MANGANESE 0.3 MG/5ML;
MANGANESE 0.59 MG/240ML;
MANGANESE 0.62 MG;
MANGANESE 0.62 MG/240ML;
MANGANESE 0.71 MG/240ML;
MANGANESE 0.75 MG/240ML;
MANGANESE 0.83 MG/240ML;
MANGANESE 0.84 MG/240ML;
MANGANESE 0.85 MG;
MANGANESE 0.85 MG/240ML;
MANGANESE 0.89 MG;
MANGANESE 0.89 MG/240ML;
MANGANESE 0.95 MG/240ML;
MANGANESE 1 MG/15ML;
MANGANESE 1.25 MG/240ML;
MANGANESE 2 MG/30ML;
MANGANESE 3.79 MCG/ML;
MANGANESE 4.34 MG/L;
MANGANESE 7.5 MG | - 82. Mantle Cell Lymphoma Stage IV
- [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow or nodular involvement of the lung(s). - 2003 ( NCI )] (UMLS (NCI) C0677721) =Neoplastic Process ;
|
- 33. manganese poisoning
- [Manganese poisoning is associated with chronic inhalation of manganese particles by individuals who work with manganese ore. Clinical features include CONFUSION; HALLUCINATIONS; and an extrapyramidal syndrome (PARKINSON DISEASE, SECONDARY) that includes rigidity; DYSTONIA; retropulsion; and TREMOR. (Adams, Principles of Neurology, 6th ed, p1213) ( MSH )] (UMLS (CSP) C0677050) =Injury or Poisoning =Heavy Metal Poisoning, Nervous System;
| - 83. manual
- [A small handbook. ( NCI )] (UMLS (CSP) C0024763) =Manufactured Object; Intellectual Product ;
|
- 34. mange
- [ ] (UMLS (CSP) C0024709) =Disease or Syndrome ;
| - 84. Manual
- [Of or related to the hands; reference to a task or activity being done by hand (as opposed as being performed with the assistance of automation or other supportive means). ( NCI )] (UMLS (NCI) C0175674) =Functional Concept ;
|
- 35. Mania
- [Excitement of psychotic proportions manifested by mental and physical hyperactivity, disorganisation of behaviour and elevation of mood. ( NCI )] (UMLS (NCI) C0338831) =Mental or Behavioral Dysfunction
| - 85. MANUAL & MECHAN TRACTION
- (UMLS (ICD9CM) C0203901) =Therapeutic or Preventive Procedure
|
- 36. mania (neurotic)
- [ ] (UMLS (CSP) C0598258) =Mental or Behavioral Dysfunction
| - 86. MANUAL ASSIST DELIV NEC
- [ ] (UMLS (ICD9CM) C0177277) =Therapeutic or Preventive Procedure
|
- 37. mania (psychotic)
- [ ] (UMLS (CSP) C0678190) =Mental or Behavioral Dysfunction ;
| - 87. Manual cell count
- [Count, Manual ( HL7V3.0 )] (UMLS (HL7) C1553120) =Laboratory Procedure =ObservationMethod;
|
- 38. Manic disorder, recurrent episode
- [ ] (UMLS (ICD9CM) C0338832) =Mental or Behavioral Dysfunction
| - 88. MANUAL EXAM OF BREAST
- [ ] (UMLS (ICD9CM) C0199851) =Diagnostic Procedure
|
- 39. Manic disorder, recurrent episode, in full remission
- [ ] (UMLS (ICD9CM) C0338839) =Mental or Behavioral Dysfunction
| - 89. MANUAL EXPLOR UTERUS P/P
- [ ] (UMLS (ICD9CM) C0195756) =Therapeutic or Preventive Procedure
|
- 40. Manic disorder, recurrent episode, in partial or unspecified remission
- [ ] (UMLS (ICD9CM) C0338838) =Mental or Behavioral Dysfunction
| - 90. MANUAL MUSCLE FUNCT TEST
- (UMLS (ICD9CM) C0204051) =Diagnostic Procedure
|
- 41. Manic disorder, recurrent episode, mild degree
- [ ] (UMLS (ICD9CM) C0154397) =Mental or Behavioral Dysfunction
| - 91. MANUAL REDUC RECT PROLAP
- [ ] (UMLS (ICD9CM) C0193270) =Therapeutic or Preventive Procedure
|
- 42. Manic disorder, recurrent episode, moderate degree
- [ ] (UMLS (ICD9CM) C0154398) =Mental or Behavioral Dysfunction
| - 92. MANUAL REDUCTION HERNIA
- (UMLS (ICD9CM) C0198793) =Therapeutic or Preventive Procedure
|
- 43. Manic disorder, recurrent episode, severe degree, specified as with psychotic behavior
- [ ] (UMLS (ICD9CM) C0154400) =Mental or Behavioral Dysfunction
| - 93. Manual removal of retained placenta
- [ ] (UMLS (ICD9CM) C0195755) =Therapeutic or Preventive Procedure
|
- 44. Manic disorder, recurrent episode, severe degree, without mention of psychotic behavior
- [ ] (UMLS (ICD9CM) C0154399) =Mental or Behavioral Dysfunction
| - 94. manual review
- [Manual review of the invoice is requested. Additional information to be supplied. This may be used in the case of an appeal. ( HL7V3.0 )] (UMLS (HL7) C1553682) =Intellectual Product =ActInvoiceOverrideCode;
|
- 45. Manic disorder, recurrent episode, unspecified degree
- [ ] (UMLS (ICD9CM) C0375164) =Mental or Behavioral Dysfunction
| - 95. MANUAL ROTAT FETAL HEAD
- [ ] (UMLS (ICD9CM) C0195704) =Therapeutic or Preventive Procedure
|
- 46. Manic Fringe
- [This protein is a member of the fringe family which also includes Radical and Lunatic fringe. They are evolutionarily conserved secreted proteins that participate in the Notch signaling pathway in determining boundaries during segmentation and cell fates during neurogenesis. (from LocusLink and OMIM) ( NCI )] (UMLS (NCI) C1334632) MFNG =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 96. MANUAL RUPT JOINT ADHES
- (UMLS (ICD9CM) C0203924) =Therapeutic or Preventive Procedure
|
- 47. Manic Fringe Homolog (Drosophila) Gene
- [This gene plays a role in signal transduction. It is involved in both embryogenesis and morphogenesis. ( NCI )] (UMLS (NCI) C1334504) MFNG;
MFNG Gene;
=Gene or Genome ;
| - 97. MANUAL RUPT OVARIAN CYST
- (UMLS (ICD9CM) C0195600) =Therapeutic or Preventive Procedure
|
- 48. Manic Psychosis
- (UMLS (NCI) C0151772) =Mental or Behavioral Dysfunction
| - 98. Manually assisted delivery
- [ ] (UMLS (ICD9CM) C0177276) =Therapeutic or Preventive Procedure
|
- 49. Manipulate
- [Move, treat, or operate with the hands or by mechanical means, especially in a skillful manner. ( NCI )] (UMLS (NCI) C0947647) Manipulation;
Manipulative =Therapeutic or Preventive Procedure | - 99. Manufacture
- [The act of making something (a product) from raw materials. ( NCI )] (UMLS (NCI) C0870840) Manufacturing =Occupational Activity ;
|
- 50. Manipulation of lacrimal passage
- [ ] (UMLS (ICD9CM) C0197393) =Therapeutic or Preventive Procedure ;
| - 100. manufactured material
- [Corresponds to the ManufacturedMaterial class ( HL7V3.0 )] (UMLS (HL7) C0024912) =Manufactured Object =Material;
=CONTAINER;
device;
|
home
